Apr 20, 2020 8:30 am EDT Acasti Pharma Awarded Notice of Allowance for Second Composition of Matter Patent in Canada
Apr 1, 2020 8:30 am EDT Acasti Pharma Submits FDA Meeting Request on Schedule, and FDA Meeting Expected in the Second Half of June
Mar 11, 2020 8:00 am EDT Acasti Pharma Awarded Notice of Allowance for Additional Composition of Matter and Method of Use Patents in the United States and Mexico
Feb 13, 2020 9:00 am EST Acasti Pharma Schedules Third Quarter Fiscal 2020 and Business Update Conference Call
Feb 10, 2020 7:00 am EST Acasti Pharma Provides Update on TRILOGY 1 and TRILOGY 2 Phase 3 Trials of CaPre
Dec 23, 2019 8:31 pm EST Acasti Pharma Provides Update on Timing of Topline Results for TRILOGY 1 Phase 3 Trial of CaPre